Research Interests

Laboratories for Innovation in Global Health Technologies (LIGHT)

The Haselton Laboratory  is an active participant in LIGHT. This is a cross-disciplinary initiative between the College of Arts and Science, the School of Engineering, and the School of Medicine. LIGHT aims to accelerate the development of global health technologies in a multidisciplinary research environment addressing the needs of patients and physicians in low-resource settings. LIGHT collaborations between researchers, users, and health practitioners nurture a growing portfolio of technologies that are at different stages of development around the world. These include the development of patient sampling devices, diagnostics for infectious diseases (malaria, TB, HIV, respiratory, and enteric) and maternal health, adherence diagnostics for treatment management, epidemiological surveillance systems, rapid prototyping tools and low-cost training tools. Our model for technology development follows ASSURED: affordable, sensitive, specific, user-friendly, rapid and robust, equipment free and deliverable to end-users, in order to create high quality products that are appropriate and affordable to the 4 billion persons at the base of the global healthcare pyramid.

Low resource extraction and processing of biological samples using surface tension valves.

This Bill & Melinda Gates Foundation funded project (with David Wright in Chemistry and Ray Mernaugh in Biochemistry) is a sample collection, concentration and preparation component for integration with downstream detection components to form a general diagnostic platform suitable for low resource environments. This self-contained processing device captures targets of interest from complex biological matrices on the surface of magnetic carrier beads which convey the biomarker targets through sequential extraction solutions to concentrate them and reduce interferents of downstream biomarker detector performance. The device has advantages over existing extraction technologies, mainly it that it can be implemented to: (1) require little or no power, (2) be suitable for an unskilled user, (3) have rapid time-to-extraction, (4) be low cost, and (5) be adaptable to multiple downstream detection designs. To our knowledge there is no currently available point-of-care extraction device that has the same level of simplicity, convenience, low cost and ease-of-use.

Enhancement of lateral flow assays for molecular detection of biomarkers of infection

While remarkable progress toward WHO recommendations for clinical confirmation of malaria has been made, passive case detection methods relying on self-referred, symptomatic individuals significantly under-estimates infection rates and do not adequately support goals toward eradication. There is an unmet need for new biomarker detection designs that increase sensitivity yet retain simplicity and easy interpretation of the user-centric lateral flow rapid diagnostic tests currently available. The most important performance criterion is sensitivity, otherwise the tool fails to support useful operational scenarios such as mass and focal testing and treatment. Existing laboratory-based designs using PCR and isothermal reactions meet this criterion but their operation is complex.

Our goal is to develop and evaluate an electricity-free nucleic acid diagnostic test. Our approach is based on a single-use cassette the size of current, well-excepted lateral flow immunoassays (LFIAs) for protein biomarker detection. This diagnostic process will require three steps with an optical read-out of the results within a total of 45-50 minutes. Blood from a finger prick is introduced into the interior of the cassette via the absorbent filter where it is mixed with pre-arrayed magnetic beads and reagents for further biomarker concentration and delivery into an isothermal reaction chamber. Biomarker transport and isothermal amplification is achieved by insertion into a reusable housing which couples to the cassette via magnetic and thermal interfaces. Final reaction product is transferred to a lateral flow strip for visual readout.

Coffee Ring Stain Diagnostics for Malaria.

In collaboration with the Wright lab (Chemistry) the goal of this project is to develop a simple, low-cost diagnostic test for malaria infection suitable for locations that lack electricity, refrigeration and highly trained technicians. The idea is based on the phenomenon that causes coffee-ring stains on the kitchen counter: When a liquid like coffee that contains a suspension of fine particles evaporates from a flat surface, the particles tend to accumulate along the outer edge. The proposed malaria test consists of two liquids and specially treated glass slides. Liquid A is mixed with the blood sample. A drop of the mixture is placed on the glass slide and left to dry. Once it has dried, the slide is washed with liquid B. If the washing reveals a purple ring, the person is infected. If it washes clean, then the person is not.

Development of DNA Logic Operations for Viral Diagnostics.

The goal of this NIH funded project (with David Wright in Chemistry, Jim Crowe in the Medical Center) is to develop and evaluate a new paradigm in virus detection. The approach is based on a combination of nanoparticle surface chemistry, tag-specific DNA sequences, and DNA ligation logical AND operators. Components of this project have been used to amplify the impact of DNA biomarkers on detection signal.

Multispectral quantum dot-based retinal imaging.

The unique optical properties of quantum dots offer the potential for new optical methods to study molecular events. This NIH funded project seeks to develop a platform for the real-time, in vivo analysis of multiple cellular and molecular events in the in vivo retina using quantum dot nanocrystals and retinal fluorescence microscopy.

Furthermore, we also seek to use novel retinal imaging agents based on quantum dots as a tool to predict the progression of atherosclerotic lesions in coronary arteries.


The Vanderbilt research environment is defined by collaboration. Only in a select few institutions across the nation can you actually toss a rock from a window in the BME department and literally break a window in the medical center (and even in a number of other science and engineering departments!). No rocks are involved, but below is a sampling of the people who we either currently collaborate with or have collaborated with especially closely.

  • David W. Wright, Department of Chemistry, Vanderbilt University [link]
  • David Aronoff, Division of Infectious Diseases, Department of Medicine, Department of Pathology, Microbiology, & Immunology, Vanderbilt University Medical Center [link]
  • David Cliffel, Department of Chemistry, Vanderbilt University [link]
  • James Crowe, Jr., Departments of Pediatric Infectious Disease and Pathology, Microbiology & Immunology, Vanderbilt University Medical Center [link]
  • Oscar Gomez-Duarte, Division of Pediactric Infectious Diseases, Department of Pathology, Microbiology, & Immunology, Vanderbilt University Medical Center [link]
  • Douglas C. Heimburger, Department of Medicine, Institute for Global Health, Vanderbilt  University Medical Center [link]
  • Ray L. Mernaugh, Department of Biochemistry, Vanderbilt University Medical Center [link]
  • William Pao, Departments of Medicine, Cancer Biology, Pathology, Microbiology & Immunology, Vanderbilt University Medical Center [link]
  • John S. Penn, Department of Opthalmology, Vanderbilt Eye Institute [link]
  • Sandy J. Rosenthal, Department of Chemistry, Vanderbilt University [link]
  • Douglas C. Schmidt, Computer Science & Engineering, Vanderbilt University [link]
  • Sten H. Vermund, Departments of Pediatrics, Health Policy, and Medicine and Assistant Vice Chancellor for Global Health, Director of the Institute for Global Health, Vanderbilt University Medical Center [link]